Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSI Creos Corporation is a diversified Japanese trading company with a significant presence in the life sciences and medical device sectors. The company specializes in the development and distribution of advanced biomaterials, including its proprietary "Carbere" cup-stacked carbon nanotubes, which are utilized in regenerative medicine and orthopedic applications. GSI Creos operates a robust medical business that provides dental materials, surgical instruments, and laboratory equipment to the global healthcare market. Beyond manufacturing, the company serves as a critical bridge for international medical technology firms seeking to enter the Japanese market through its extensive distribution network. Their focus remains on integrating nanotechnology with healthcare to improve outcomes in bone and tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GSI Creos.